Z. Herrmann

Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma

Hans D. Menssen, A Sakalová, A Fontana et al. · Journal of Clinical Oncology · 2002 · 159 citations

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia

D. Thiébaud, Z. Herrmann, EU Steinhauer et al. · British Journal of Cancer · 1997 · 130 citations · Full text

Bone Disease, Medicine, Pharmacology +8

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.

Martin Pecherstorfer, Z. Herrmann, Jean‐Jacques Body et al. · Journal of Clinical Oncology · 1996 · 127 citations

Efficacy and Safety of Recombinant Human Erythropoietin to Prevent the Anaemias of Prematurity

Michael Obladen, Rolf F. Maier, Hugo Segerer et al. · Contributions to nephrology · 2015 · 56 citations · Full text

Rolf Maier, Neonatology, Fertility +15

Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study

Manfred Heim, M.R. Clemens, W. Queißer et al. · Oncology Research and Treatment · 1995 · 52 citations

Prospective Randomized Trial, Dichloromethylene Bisphosphonate, Osteoporosis +17